Cencora is ranked #11 on the Fortune 500 and #24 on the Global Fortune 500 with more than $200 billion in annual revenue. Learn more at www.cencora.com Contacts ...

Alto and Cencora are collaborating to deliver enhanced patient support services and streamline access to prescribed specialty medications. The collaboration leverages Cencora’s patient support ...

Cencora now forecasts 10% to 12% revenue growth in FY2024, up from the previous forecast of 7% to 10%. On an adjusted basis, Cencora reported a profit of $3.28 per share, beating LSEG estimates of ...